LEADER 04126nam  2200985 a 450 
001 9910958408603321
005 20251017110056.0
010   $a9786612239243
010   $a9780309141093
010   $a0309141095
010   $a9781282239241
010   $a1282239244
010   $a9780309130400
010   $a0309130409
035   $a(CKB)1000000000787845
035   $a(EBL)3378500
035   $a(SSID)ssj0000200515
035   $a(PQKBManifestationID)11220485
035   $a(PQKBTitleCode)TC0000200515
035   $a(PQKBWorkID)10220290
035   $a(PQKB)10335407
035   $a(MiAaPQ)EBC3378500
035   $a(Au-PeEL)EBL3378500
035   $a(CaPaEBR)ebr10315882
035   $a(CaONFJC)MIL223924
035   $a(OCoLC)923280394
035   $a(Perlego)4733772
035   $a(DNLM)1513534
035   $a(EXLCZ)991000000000787845
100   $a20091008d2009      uy         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aMedical isotope production without highly enriched uranium /$fCommittee on Medical Isotope Production Without Highly Enriched Uranium, Nuclear and Radiation Studies Board, Division of Earth and Life Studies, National Research Council of the National Academies
205   $a1st ed.
210   $aWashington, D.C. $cNational Academies Press$d2009
215   $a1 online resource (221 p.)
300   $aDescription based upon print version of record.
311 08$aPrint version: Washington, D.C. : National Academies Press, ©2009 (OCoLC)310392635 
320   $aIncludes bibliographical references (p. 163-167).
327   $aBackground and study task -- Molybdenum-99/Technetium-99m production and use -- Molybdenum-99/Technetium-99m supply -- Molybdenum-99/Technetium-99m supply reliability -- Molybdenum-99/Technetium-99m demand -- Molybdenum-99/Technetium-99m production costs -- Conversion to LEU-based production of Molybdenum-99: technical considerations -- Conversion to LEU-based production of Molybdenum-99: regulatory considerations -- Conversion to LEU-based production of Molybdenum-99: general approaches and timing -- Conversion to LEU-based production of Molybdenum-99: prospects and feasibility.
606   $aUranium$xIsotopes$xTherapeutic use
606   $aHighly enriched uranium$xIsotopes$xTherapeutic use
606   $aMolybdenum$xIsotopes$xTherapeutic use
606   $aTechnetium$xIsotopes$xTherapeutic use
606   $aRadioisotopes$xTherapeutic use
606   $aNuclear medicine$xStandards$zUnited States
606   $aDiagnostic imaging
606   $aRadionuclide generators
606   $aQuality control
606   $aMolybdenum$xsupply & distrubution
606   $aMolybdenum$xisolation & purification
606   $aRadioisotopes$xsupply & distribution
606   $aTechnetium Compounds$xisolation & purification
606   $aDiagnostic Imaging
606   $aRadionuclide Generators
606   $aQuality Control
607   $aUnited States
615  0$aUranium$xIsotopes$xTherapeutic use.
615  0$aHighly enriched uranium$xIsotopes$xTherapeutic use.
615  0$aMolybdenum$xIsotopes$xTherapeutic use.
615  0$aTechnetium$xIsotopes$xTherapeutic use.
615  0$aRadioisotopes$xTherapeutic use.
615  0$aNuclear medicine$xStandards
615  0$aDiagnostic imaging.
615  0$aRadionuclide generators.
615  0$aQuality control.
615 12$aMolybdenum$xsupply & distrubution.
615 22$aMolybdenum$xisolation & purification.
615 22$aRadioisotopes$xsupply & distribution.
615 22$aTechnetium Compounds$xisolation & purification.
615 22$aDiagnostic Imaging.
615 22$aRadionuclide Generators.
615 22$aQuality Control.
676   $a546.431
712 02$aNational Research Council (U.S.).$bNuclear and Radiation Studies Board.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910958408603321
996   $aMedical isotope production without highly enriched uranium$94344155
997   $aUNINA